ARNT
MOLECULAR TARGETaryl hydrocarbon receptor nuclear translocator
ARNT (aryl hydrocarbon receptor nuclear translocator) is targeted by 7 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ARNT
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Aminoimidazole Carboxamide | 1.10 | 2 |
| 2 | Histamine | 1.10 | 2 |
| 3 | cefaclor | 0.69 | 1 |
| 4 | Cefdinir | 0.69 | 1 |
| 5 | Oxytetracycline | 0.69 | 1 |
| 6 | streptonigrin | 0.69 | 1 |
| 7 | Thioridazine | 0.69 | 1 |
About ARNT as a Drug Target
ARNT (aryl hydrocarbon receptor nuclear translocator) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 7 compounds with documented ARNT interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ARNT inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.